Lidoposterin (Lidocaine)

Lidocaine blocks voltage‑gated sodium channels on nerve membranes, preventing the rapid influx of sodium ions needed for depolarisation. This inhibition stops the generation and conduction of nerve impulses, resulting in reversible loss of sensation in the treated area.

The appropriate dose of Lidoposterin is determined by the prescribing clinician based on the treatment area, patient age, and clinical context. Healthcare professionals calculate the amount to apply or administer in accordance with local guidelines and product labeling.

Safety data for lidocaine in pregnancy and lactation are limited. Use is generally reserved for situations where the benefit outweighs potential risk, and it should only be administered under medical supervision. Pregnant or nursing individuals should discuss any concerns with their healthcare provider.

To request Lidoposterin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Lidocaine is an amide‑type local anesthetic with a rapid onset and moderate duration, making it suitable for short‑term procedures. Compared with ester‑type agents such as procaine, lidocaine has a lower risk of allergic reactions and a longer half‑life, offering more predictable analgesia for cutaneous and rectal applications.

Lidoposterin should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and direct light. Keep the container tightly closed and avoid exposing the product to extreme temperatures or humidity.

Lidoposterin is applied topically to intact skin or rectal mucosa. The clinician spreads a thin layer over the target area, following the product’s instructions for maximum surface area and contact time. No injection or oral ingestion is involved.

The most serious risks include systemic toxicity, which can manifest as central nervous system symptoms (e.g., seizures, dizziness) or cardiac effects (arrhythmias, hypotension). Rare allergic reactions such as anaphylaxis and methemoglobinemia may also occur, requiring immediate medical attention.

Individuals with a known hypersensitivity to lidocaine or other amide‑type local anesthetics should avoid Lidoposterin. It is also contraindicated on severely damaged or infected skin, and caution is advised in patients with significant cardiac, hepatic or renal impairment.